STELARA® (USTEKINUMAB) DATA DEMONSTRATE LONG-TERM EFFICACY AND SAFETY RESULTS IN ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN PHASE 3 EXTENSION TRIAL
- EMEA Innovative Medicine
- STELARA® (USTEKINUMAB) DATA DEMONSTRATE LONG-TERM EFFICACY AND SAFETY RESULTS IN ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN PHASE 3 EXTENSION TRIAL
STELARA® (USTEKINUMAB) DATA DEMONSTRATE LONG-TERM EFFICACY AND SAFETY RESULTS IN ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN PHASE 3 EXTENSION TRIAL
- X (Twitter)
Copy link